Full name
EXIM PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.89.Z - Production of other food products, not elsewhere classified
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46.46.Z - Wholesale trade of pharmaceutical and medical products
47 - Retail trade
52 - Warehousing, storage, and support activities for transport
52.10 - Warehousing and storage of goods
77 - Rental and leasing
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 1,2 | 5,1 | 325,9 |
EBITDA | 0,9 | 1,5 | 5,5 | 279,6 |
Short time liabilities | 1,1 | 3,6 | 6,5 | 79,3 |
Equity capital | 1,4 | 2,4 | 6,5 | 175,3 |
Operating profit (EBIT) | 0,8 | 1,2 | 5,3 | 344,4 |
Assets | 2,5 | 6 | 13,1 | 117,2 |
Net profit (loss) | 0,7 | 1 | 4,2 | 328,8 |
Cash | 1,4 | 2,9 | 4 | 39,2 |
Net income from sale | 4,9 | 16,3 | 34,1 | 108,9 |
Liabilities and provisions for liabilities | 1,1 | 3,6 | 6,5 | 79,3 |
Working assets | 2 | 4,3 | 7,8 | 81,6 |
Depreciation | 0,1 | 0,3 | 0,2 | -17,1 |
% | % | % | p.p. | |
Profitability of capital | 49,4 | 40,9 | 63,7 | 22,8 |
Equity capital to total assets | 56,3 | 39,4 | 50 | 10,6 |
Gross profit margin | 15,2 | 7,4 | 15 | 7,6 |
EBITDA Margin | 17,6 | 8,9 | 16,2 | 7,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 80 | 81 | 70 | -11 |
Current financial liquidity indicator | 1.8760511875152588 | 1.184531569480896 | 1.199711799621582 | 0 |
Net dept to EBITDA | -1.5845338106155396 | -1.9854599237442017 | -0.7285552620887756 | 1,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane